This inventor holds 1 USPTO granted patent. Top assignee: Instituto Butantan. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Roger Chammas: Innovator in Pharmaceutical Sciences
Introduction
Roger Chammas is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the fields of pharmaceutical sciences and immunology. His work focuses on developing innovative methods for treating cancer through the modulation of innate immune pathways.
Latest Patents
Roger Chammas holds a patent for a compound that modulates RLR, TLR, OAS, and/or oncostatin M pathways. This invention is particularly relevant for preparing medicines and pharmaceutical compositions aimed at treating cancer. The compound, derived from amblyomin-X, offers a novel approach to enhancing immune responses against tumors.
Career Highlights
Roger Chammas is affiliated with Instituto Butantan, a prominent research institution in Brazil. His work at this institute has allowed him to explore groundbreaking research in immunology and cancer treatment. His dedication to advancing medical science is evident through his innovative patent.
Collaborations
Roger has collaborated with esteemed colleagues such as Ana Marisa Chudzinski Tavassi and Maurício Barbugiani Goldfeder. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field.
Conclusion
Roger Chammas exemplifies the spirit of innovation in pharmaceutical sciences. His contributions to cancer treatment through the modulation of immune pathways highlight the importance of research and development in medicine. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile